Drugs that contain Benzoyl Peroxide; Clindamycin Phosphate

1. Drug name - ACANYA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9078870 BAUSCH Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent Jun, 2029

(6 years from now)

US9561208 BAUSCH Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent Jun, 2029

(6 years from now)

US10220049 BAUSCH Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent Jun, 2029

(6 years from now)

US9504704 BAUSCH Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent Jun, 2029

(6 years from now)

US8895070 BAUSCH Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent Jun, 2029

(6 years from now)

US10137142 BAUSCH Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent Jun, 2029

(6 years from now)

US10624918 BAUSCH Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent Jun, 2029

(6 years from now)

US8663699 BAUSCH Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent Jun, 2029

(6 years from now)

US8288434 BAUSCH Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent Aug, 2029

(6 years from now)

Treatment: Topical treatment of acne vulgaris in patients 12 years or older; Treatment of acne vulgaris; topical treatment of acne vulgaris; topical treatment of acne vulgaris in patients 12 years or older; treatment of acne; Treatment of acne; Topical treatment of acne vulgaris; treatment of acne; treatment of acne vulgaris; topical treatment of acne vulgaris; treatment of acne vulgaris; topical treatment of acne vulgaris in patients 12 years or older

Dosage: GEL;TOPICAL

More Information on Dosage
Strength Dosage Availability
2.5%;EQ 1.2% BASE GEL;TOPICAL Prescription
3.75%;EQ 1.2% BASE GEL;TOPICAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.